BNR
NASDAQ
CN
Burning Rock Biotech Limited - American Depositary Shares
$16.20
▼ $-0.10
(-0.61%)
Vol 56K
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$216.9M
ROE
-21.4%
Margin
-22.5%
D/E
0.36
Beta
1.41
52W
$2–$24
Wall Street Consensus
5 analysts · Jan 20241
Strong Buy
3
Buy
1
Hold
0
Sell
0
Strong Sell
80.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 25.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Sep 2022 | $-23.74 | $-22.30 | +$1.44 |
| Jun 2022 | $-24.24 | $-25.00 | $-0.76 |
| Mar 2022 | $-24.34 | $-25.00 | $-0.66 |
| Dec 2021 | $-17.07 | $-24.00 | $-6.93 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | $128.6M | $126.0M | $133.1M | $148.6M | $131.6M | — |
| Net Income | -$35.7M | -$81.3M | -$13.5M | -$9.7M | -$16.8M | — |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -23.7% | -38.5% | -23.7% | -23.7% | -21.4% | -21.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -6.5% | -45.6% | -26.1% | -26.1% | -22.5% | -22.5% |
| Gross Margin | 72.8% | 71.5% | 72.1% | 72.1% | 73.0% | 73.0% |
| D/E Ratio | 0.35 | 0.00 | 0.35 | 0.35 | 0.36 | 0.36 |
| Current Ratio | 3.22 | 3.02 | 3.22 | 3.22 | 3.14 | 3.14 |
Key Ratios
ROA (TTM)
-14.4%
P/S (TTM)
2.81
P/B
0.8
EPS (TTM)
$-1.16
Rev Growth 3Y
+0.5%
52W High
$24.18
52W Low
$2.18
$2.18
52-Week Range
$24.18
Financial Health
Free Cash Flow
$16.4M
Net Debt
-$430.8M
Cash
$464.0M
Total Debt
$33.2M
As of Sep 30, 2025
How does BNR compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
BNR valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
2.8
▼
78%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
0.8
▼
66%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
BNR profitability vs Biotechnology peers
ROE
-21.4%
▲
68%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-22.5%
▲
92%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
73.0%
▼
7%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-14.4%
▲
69%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
BNR financial health vs Biotechnology peers
D/E ratio
0.4
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
3.1
▼
29%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.4
▲
45%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
BNR fundamentals radar
BNR
Peer median
Industry
BNR profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BNR vs peers: key metrics
Top Holders
Top 5: 17.5%Kynam Capital Management, LP
11.01%
$16.3M
CRCM LP
5.44%
$8.0M
Sumitomo Mitsui Trust Group…
0.35%
$520K
Amova Asset Management Amer…
0.35%
$520K
Prospera Financial Services…
0.35%
$510K
As of Dec 31, 2025
Latest News
No related news yet